Abnormal neurogenesis and cortical growth in congenital heart disease
A research team led by Children’s National Hospital uses a preclinical model to demonstrate that SVZ NSPCs contribute to perinatal corticogenesis and to suggest that restoration of SVZ NSPCs’ neurogenic potential is a candidate therapeutic target for improving cortical growth in CHD. Children's researchers featured in the video include: Vittorio Gallo, Ph.D., Richard Jonas, M.D., Paul Morton, Ph.D. and Nobuyuki Ishibashi, M.D.
Related research article
About the Expert
Vittorio Gallo, Ph.D.
Chief Research Officer, Children’s National Hospital & Scientific Director, Children’s National Research Institute
Associate Dean for Child Health Research, GWU School of Medicine & Health Sciences
Director, DC Intellectual & Developmental Disabilities Research Center & Wolf-Pack Chair in Neuroscience
Nobuyuki Ishibashi, M.D.
Foglia-Hills Professor of Pediatric Cardiac Research
Director of Cardiac Surgery Research Laboratory
Principal Investigator
Richard Jonas, MD
Emeritus Chief, Cardiac Surgery
Senior Investigator, Center for Neuroscience Research